May 28, 2019 - Teva Pharmaceutical Industries (TEVA -12.9%) commences the U.S. commercial launch of its generic version of Gilead Sciences' (GILD -3.2%) angina med Ranexa (ranolazine) Extended-Release Tablets, 500 m
May 28, 2019 - Tough industry conditions took their toll on some stocks.
May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
May 29, 2019 - Companies in the news are:
UBER, TEVA, AMD and ASGN
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Jun 13, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day.
Jun 17, 2019 - Here are the biggest calls on Wall Street on Monday
Jun 18, 2019 - TEVA's generic revenues are surprisingly resilient against Medicare reform.The company's top notch pipeline and product launches have the ability to offset the generic drug apocalypse.Investor capitul
Jun 20, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.12 in the latest trading session, marking a -0.73% move from the prior day.